Maximus Stock Price, News & Analysis (NYSE:MMS)

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Maximus in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" MMS shares.
View MMS analyst ratings or view top-rated stocks.

2 brokerages have issued 1 year price targets for Maximus' shares. Their MMS share price targets range from $100.00 to $102.00. On average, they predict the company's share price to reach $101.00 in the next twelve months. This suggests a possible upside of 18.2% from the stock's current price.
View analysts price targets for MMS or view top-rated stocks among Wall Street analysts.

Maximus' stock was trading at $73.33 at the start of the year. Since then, MMS shares have increased by 16.5% and is now trading at $85.46.
View the best growth stocks for 2023 here.

Maximus saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 977,400 shares, an increase of 29.1% from the October 31st total of 756,800 shares. Based on an average daily volume of 282,900 shares, the short-interest ratio is currently 3.5 days. Currently, 1.6% of the shares of the company are sold short.
View Maximus' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 14th 2024.
View our MMS earnings forecast.

Maximus, Inc. (NYSE:MMS) issued its quarterly earnings results on Wednesday, November, 15th. The health services provider reported $1.29 earnings per share for the quarter, missing the consensus estimate of $1.34 by $0.05. The health services provider had revenue of $1.26 billion for the quarter, compared to the consensus estimate of $1.27 billion. Maximus had a trailing twelve-month return on equity of 14.46% and a net margin of 3.30%. Maximus's revenue was up 7.0% compared to the same quarter last year. During the same period last year, the company posted $1.40 EPS.

Maximus declared a quarterly dividend on Tuesday, October 10th. Investors of record on Wednesday, November 15th will be given a dividend of $0.30 per share on Thursday, November 30th. This represents a $1.20 dividend on an annualized basis and a yield of 1.40%. The ex-dividend date of this dividend is Tuesday, November 14th. This is a boost from the stock's previous quarterly dividend of $0.28.
Read our dividend analysis for MMS.

Maximus (NYSE:MMS) pays an annual dividend of $1.20 per share and currently has a dividend yield of 1.41%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 45.63%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, MMS will have a dividend payout ratio of 21.02% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MMS.

ETFs with the largest weight of Maximus (NYSE:MMS) stock in their portfolio include Natixis Vaughan Nelson Mid Cap ETF (VNMC), ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM), Fidelity Digital Health ETF (FDHT), Running Oak Efficient Growth ETF (RUNN), Nuveen Small Cap Select ETF (NSCS), iShares MSCI USA Small-Cap Min Vol Factor ETF (SMMV), Fidelity Low Volatility Factor ETF (FDLO) and First Trust Multi-Manager Small Cap Opportunities ETF (MMSC).

Maximus updated its FY24 earnings guidance on Wednesday, November, 15th. The company provided EPS guidance of $5.05-5.35 for the period, compared to the consensus estimate of $4.55. The company issued revenue guidance of $5.05-5.20 billion, compared to the consensus revenue estimate of $5.18 billion.

145 employees have rated Maximus Chief Executive Officer Bruce Caswell on Glassdoor.com. Bruce Caswell has an approval rating of 80% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Maximus investors own include Pfizer (PFE), Lennar (LEN), AbbVie (ABBV), Cisco Systems (CSCO), Kroger (KR), Skyworks Solutions (SWKS), Advanced Micro Devices (AMD), Cerner (CERN), Intel (INTC) and JD.com (JD).

Maximus' stock is owned by a variety of institutional and retail investors. Top institutional investors include FMR LLC (14.13%), Victory Capital Management Inc. (9.43%), Mackenzie Financial Corp (4.36%), Van Berkom & Associates Inc. (1.85%), Fuller & Thaler Asset Management Inc. (1.71%) and Northern Trust Corp (1.31%). Insiders that own company stock include Bruce Caswell, David Francis, David Mutryn, Ilene R Baylinson, Michael J Warren, Michelle F Link, Peter Pond, Raymond B Ruddy, Richard A Montoni, Richard John Nadeau, Teresa Weipert and Thomas D Romeo.
View institutional ownership trends.

Shares of MMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.